COc1ccc(C2=C(C(C)=O)Sc3nnc(-c4ccc(Cl)cc4)n3N2C(C)=O)cc1OC
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?